Top compounds associated with response to RPEL1


Feature Type Standardized
Nominal ANOVA
mRNA PD173074 GDSC1000 pan-cancer AAC -0.016 0.6
mRNA etomoxir CTRPv2 pan-cancer AAC -0.019 0.6
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.015 0.6
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA niclosamide CTRPv2 pan-cancer AAC 0.018 0.6
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA lapatinib CTRPv2 pan-cancer AAC 0.017 0.6
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA triptolide CTRPv2 pan-cancer AAC -0.017 0.6
Download CSV